Back
X4 Pharmaceuticals Stock Price Chart

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
28
XFOR
X4 Pharmaceuticals
Last Price:
$0.22
Seasonality Move:
14.76%
7 Day Trial
ALL ACCESS PASS
$
7

Marketing's AI Disruption Is Now Secure Your Stake Today!
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XFOR is experiencing slight selling pressure.
X4 Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.27 | Sell |
20-day SMA: | 0.31 | Sell |
50-day SMA: | 0.43 | Sell |
200-day SMA: | 0.59 | Sell |
8-day EMA: | 0.27 | Sell |
20-day EMA: | 0.32 | Sell |
50-day EMA: | 0.4 | Sell |
200-day EMA: | 0.6 | Sell |
X4 Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 29.45 | Sell |
Chaikin Money Flow: | -237719 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.27 - 0.39) | Sell |
Bollinger Bands (100): | (0.34 - 0.64) | Sell |
X4 Pharmaceuticals Technical Analysis
Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for X4 Pharmaceuticals Stock
Is X4 Pharmaceuticals Stock a Buy?
-
X4 Pharmaceuticals share price is 0.24 while XFOR 8-day simple moving average is 0.27, which is a Sell signal.
-
The stock price of XFOR is 0.24 while X4 Pharmaceuticals 20-day SMA is 0.31, which makes it a Sell.
-
X4 Pharmaceuticals 50-day simple moving average is 0.43 while XFOR share price is 0.24, making it a Sell technically.
-
XFOR stock price is 0.24 and X4 Pharmaceuticals 200-day simple moving average is 0.59, creating a Sell signal.
XFOR Technical Analysis vs Fundamental Analysis
Sell
28
X4 Pharmaceuticals (XFOR)
is a Sell
Is X4 Pharmaceuticals a Buy or a Sell?
-
X4 Pharmaceuticals stock is rated a SellThe current X4 Pharmaceuticals [XFOR] share price is $0.24. The Score for XFOR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
X4 Pharmaceuticals Stock Info
Market Cap:
41.1M
Price in USD:
0.24
Share Volume:
2.1M
X4 Pharmaceuticals 52-Week Range
52-Week High:
1.60
52-Week Low:
0.23
Sell
28
X4 Pharmaceuticals (XFOR)
is a Sell
X4 Pharmaceuticals Share Price Forecast
-
What is the X4 Pharmaceuticals stock price today?The X4 Pharmaceuticals stock price is 0.24 USD today.
-
Will XFOR stock go up or go down?X4 Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is X4 Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, X4 Pharmaceuticals is overvalued.
Is X4 Pharmaceuticals Stock a Buy?
-
X4 Pharmaceuticals share price is 0.24 while XFOR 8-day exponential moving average is 0.27, which is a Sell signal.
-
The stock price of XFOR is 0.24 while X4 Pharmaceuticals 20-day EMA is 0.32, which makes it a Sell.
-
X4 Pharmaceuticals 50-day exponential moving average is 0.40 while XFOR share price is 0.24, making it a Sell technically.
-
XFOR stock price is 0.24 and X4 Pharmaceuticals 200-day simple moving average is 0.60, creating a Sell signal.
Fundamental Analysis of X4 Pharmaceuticals
Is X4 Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.30 per share, and an increase next year of $0.08 per share.
Technical Analysis of X4 Pharmaceuticals
Should I short X4 Pharmaceuticals stock?
-
XFOR Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting X4 Pharmaceuticals is a Sell
-
X4 Pharmaceuticals Relative Strength Index (RSI) is 29.45, which suggest X4 Pharmaceuticals is oversold
-
The Bollinger Bands (25) for X4 Pharmaceuticals is (0.27 - 0.39), which suggest X4 Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for X4 Pharmaceuticals is (0.34 - 0.64), which suggest X4 Pharmaceuticals is a Sell
* X4 Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.